Author: MyHairline Editorial Team Editorial review: MyHairline medical content review. Named clinician reviewer pending verified reviewer relationship and crawlable bio. Last updated: May 2026
Educational use only. This article is not medical advice. Frontal fibrosing alopecia is a scarring (cicatricial) alopecia. A board-certified dermatologist must direct diagnosis and treatment. The Myhairline.ai analyzer is an educational classification tool and is not designed to diagnose scarring alopecias.
The Hairline That Wasn't "Just Aging"
Rachel, 54, from Scottsdale, noticed her hairline creeping back in early 2024. She figured it was menopause. Her hairdresser figured it was menopause. She spent four months on over-the-counter minoxidil and a biotin supplement before a friend, a nurse, pointed out that her eyebrows had thinned too, mostly the outer third.
"I showed up at the dermatologist thinking I'd get a finasteride prescription and leave," Rachel told me. "Instead, she pulled out a dermoscope, spent 20 minutes on my hairline, and said the words I'd never heard: frontal fibrosing alopecia."
Her punch biopsy confirmed it two weeks later. By that point she'd lost roughly 1.5 centimeters of frontal hairline, and that hair was never coming back.
Rachel's story is painfully common. The Norwood Scale describes androgenetic alopecia, the genetically driven, non-scarring hair loss pattern responsible for the vast majority of male hairline recession (and a meaningful share of female recession, too). But not every receding hairline fits the Norwood template. A subset of people, especially post-menopausal women but also men, present with a band of frontal recession that looks superficially like a Norwood 2 or 3 yet is driven by a fundamentally different disease. The most clinically important of those diseases is frontal fibrosing alopecia (FFA), and it is the diagnosis most often missed by readers who try to self-classify on a Norwood chart.
FFA was first described by Steven Kossard in Archives of Dermatology in 1994. It's now recognized as a clinical variant of lichen planopilaris, an inflammatory scarring alopecia. The hallmark: a progressive, band-like recession of the frontal and temporal hairline, frequently accompanied by eyebrow loss, perifollicular redness, and a pale, almost porcelain-white look to the affected skin.
Here's the thing that separates FFA from androgenetic alopecia in the starkest possible terms: FFA destroys the follicle through inflammation and fibrosis. Lost hair does not regrow. That single fact is why early diagnosis and treatment matter so much, and why every person with a retreating hairline benefits from understanding the distinction.
Red Flags That Point to FFA Instead of Garden-Variety Recession
Several features should send someone straight to a dermatologist rather than to the pharmacy aisle.
The recession pattern is uniform and band-like. Not V-shaped at the temples, not a widening part. Band-like. The skin behind the retreating hairline often looks pale, atrophic, or shiny rather than normally pigmented. Eyebrow thinning (particularly the lateral brow) shows up in roughly 73 percent of FFA cases, according to a 2014 multicenter case series in the Journal of the American Academy of Dermatology. "Lonely hairs," isolated terminal strands sitting in the recession zone with no neighbors, are a classic trichoscopic sign. And itching or burning at the hairline, something that essentially never accompanies androgenetic alopecia, is reported by a substantial minority of FFA patients.
If you have a receding hairline that itches, lost eyebrow hair, or that pale-skin pattern, stop Googling Norwood stages and book a dermatologist visit. Seriously.
How Dermatologists Nail Down the Diagnosis
Diagnosis is clinical, trichoscopic, and sometimes histopathologic. A typical workup begins with a detailed history, a full scalp and brow exam, dermoscopy of the hairline, and date-stamped photographs for future comparison. When the trichoscopic picture isn't clear-cut, a small punch biopsy of an actively inflamed border lesion is the gold standard. Biopsy distinguishes FFA from traction alopecia, alopecia areata, central centrifugal cicatricial alopecia (CCCA), and androgenetic alopecia with reasonable specificity.
A note on the Myhairline.ai analyzer: it's calibrated for androgenetic Norwood classification. It does not attempt to diagnose scarring alopecia. If your photo shows band-like frontal recession with eyebrow involvement or porcelain skin, treat any AI result as preliminary at best. Prioritize an in-person evaluation.
What Treatment Actually Looks Like (and What It Can't Do)
All therapeutic decisions require a licensed dermatologist. What follows is informational, not prescriptive.
The therapeutic goal in FFA is stabilization. Not regrowth. Not cure. Stabilization. No therapy reverses scarring, regrows hair in fully scarred zones, or eliminates the disease. This is the most important sentence in the entire article, and it's the sentence that separates the FFA conversation from the androgenetic conversation in the sharpest way.
5-alpha-reductase inhibitors carry the strongest published evidence for halting FFA progression. A 2018 multicenter case series in the Journal of the American Academy of Dermatology of 224 FFA patients reported stabilization of hairline recession in 47 percent of patients on dutasteride and 53 percent on finasteride over an average follow-up of 18 months. Those are stabilization figures, not regrowth figures. Read them that way.
Hydroxychloroquine, an antimalarial with anti-inflammatory properties, has been used in lichen planopilaris and FFA for two decades. Published case series in JAMA Dermatology and elsewhere report stabilization rates in the 30 to 50 percent range. It requires ophthalmologic monitoring and isn't appropriate for everyone.
Topical and intralesional corticosteroids (clobetasol, intralesional triamcinolone) are first-line adjuncts. They reduce perifollicular inflammation and are most useful early, before extensive scarring has set in.
Oral retinoids, specifically low-dose isotretinoin and acitretin, have published evidence in lichen planopilaris and have been used off-label for FFA. Stabilization rates are broadly similar to hydroxychloroquine in smaller case series.
Calcineurin inhibitors (topical tacrolimus, pimecrolimus) are sometimes deployed to calm perifollicular inflammation without the long-term downsides of steroids.
JAK inhibitors represent the newest frontier. A small but growing collection of case reports in journals including JAMA Dermatology describe stabilization with oral JAK inhibitors. This is not standard of care as of 2026, but it's where a lot of the clinical attention is heading.
How Most Dermatologists Sequence These Drugs
In practice, most dermatologists start with a 5-alpha-reductase inhibitor plus a topical or intralesional steroid for active inflammation. If the hairline keeps moving over six to twelve months of documented therapy, they escalate to hydroxychloroquine or an oral retinoid. Treatment is long-term. Stopping often triggers reactivation.
I'm not going to lay out a step-by-step protocol here, and I'd be suspicious of any article that does. FFA management is genuinely individualized. Comorbid conditions, pregnancy status, baseline labs, ophthalmologic status, disease activity: all of these shift the decision tree. The published case series offer probability ranges. They don't offer recipes.
What "Success" Actually Means With FFA
A 2017 review in Skin Appendage Disorders of FFA cohorts followed for more than three years found that approximately 70 percent of patients on appropriate therapy achieve stable disease, defined as no further measurable hairline recession over the follow-up window. Roughly 15 percent continue slow progression despite treatment. The rest show intermittent activity. Hair regrowth in fully scarred zones does not occur. Hair that was not yet fully miniaturized when treatment started sometimes recovers, but planning around regrowth is not realistic.
The boring truth is that "success" in FFA means the hairline stops moving. That might sound underwhelming compared to the before-and-after photos on androgenetic alopecia subreddits. But for a disease that, left untreated, can strip the entire frontal hairline and both eyebrows, stabilization is a genuinely meaningful outcome.
For established scarring, cosmetic options include scalp micropigmentation, wigs, hair systems, and (in carefully selected stable cases) hair transplantation. Transplanting into FFA-affected scalp is controversial. Published case series describe variable graft survival and risk of disease reactivation in the transplanted zone. Most experienced surgeons require at least two years of documented disease stability before they'll consider surgical restoration.
If You Think This Might Be You
Stop self-treating with over-the-counter minoxidil as your only intervention. It's like putting a band-aid on a structural crack in your foundation. Document your hairline, brows, and any symptoms with date-stamped photographs. Book an evaluation with a board-certified dermatologist, ideally one with a subspecialty interest in hair disorders or scarring alopecias. Ask whether trichoscopy is part of the consultation and whether a biopsy is warranted.
If FFA is confirmed, begin treatment promptly. Every month of unchecked inflammation is follicles you don't get back.
Common Questions About Frontal Fibrosing Alopecia
Is FFA contagious or genetic? FFA is not contagious. A genetic component is suspected based on familial clustering in some published case series, but a single causative gene has not been identified. Hormonal, environmental, and autoimmune contributions are all under active investigation.
Why are post-menopausal women most affected? The original Kossard 1994 series described FFA in post-menopausal women, and that remains the largest patient subgroup in published cohorts. The estrogen decline of menopause may contribute by removing a partial protective influence on the hair follicle. Pre-menopausal women and men can also develop FFA. The disease is now diagnosed across a wider demographic than originally recognized.
Can men get frontal fibrosing alopecia? Yes. Male FFA is increasingly reported in the dermatology literature, including a 2018 case series in JAMA Dermatology. Male FFA is often misdiagnosed as androgenetic alopecia because the band-like recession can mimic a Norwood 3 hairline. Trichoscopic and biopsy features distinguish the two.
Is sunscreen linked to FFA? Several epidemiologic studies, including a 2016 British Journal of Dermatology case-control analysis, identified an association between facial sunscreen use and FFA in women. The association is statistically significant but does not establish causation. Most experts treat the data as hypothesis-generating, not as a reason to stop wearing sunscreen, given its established role in preventing skin cancer.
How is FFA different from traction alopecia? Traction alopecia results from sustained mechanical pulling on the hair, typically from tight hairstyles or hair systems. Early traction alopecia is non-scarring and reversible if the traction stops. Long-standing traction alopecia can become scarring. The history (sustained traction) and distribution (matching the pull pattern) distinguish it from FFA.
If my hairline has been stable for years, do I still need treatment? Possibly. FFA can reactivate after periods of apparent quiescence. Most dermatologists continue monitoring (and often continue low-dose therapy) even during stable phases. Discontinuation decisions are made on a case-by-case basis with clinical follow-up.
Continue Reading Across the Receding Hairline Cluster
This page is the cluster hub for the Receding Hairline cluster on Myhairline.ai. The pillar overview lives at The Norwood Scale: Complete Guide. Within this cluster, supporting articles cover the most-searched sub-questions:
- Frontal Fibrosing Alopecia Cure: Complete Guide, why "cure" is the wrong word and what realistic outcomes look like.
- Frontal Alopecia Treatment: Complete Guide, broader treatment landscape across frontal alopecia subtypes.
- Frontal Fibrosing Alopecia Success Stories: Complete Guide, case-based outcomes literature and patient-reported experience.
- Hairline Test: Complete Guide, at-home self-assessment for hairline change tracking.
- Hairline Check: Complete Guide, visual and trichoscopic checks dermatologists use.
- Rogaine For Hairline: Complete Guide, what minoxidil does and does not do at the frontal hairline.
- Best Hairline Transplant in 2026, what makes a hairline transplant outcome look natural.
- Turkey Hairline Transplant Cost - Real Numbers, published pricing ranges and what they include.
- Hairline Lowering Lift Worcester: Complete Guide, surgical hairline lowering as a non-transplant option.
- The Norwood Scale: Complete Guide to Male Pattern Hair Loss Stages, the full pillar context.
Key References
Kossard S. Postmenopausal frontal fibrosing alopecia: scarring alopecia in a pattern distribution. Archives of Dermatology. 1994;130(6):770-774.
Vano-Galvan S, Molina-Ruiz AM, Serrano-Falcon C, et al. Frontal fibrosing alopecia: a multicenter review of 355 patients. Journal of the American Academy of Dermatology. 2014;70(4):670-678.
Rácz E, Gho C, Moorman PW, Noordhoek Hegt V, Neumann HA. Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review. Journal of the European Academy of Dermatology and Venereology. 2013;27(12):1461-1470.
Murad A, Bergfeld W. 5-alpha-reductase inhibitor treatment for frontal fibrosing alopecia: an evidence-based approach. International Journal of Women's Dermatology. 2018;4(3):153-158.
Strazzulla LC, Avila L, Lo Sicco K, Shapiro J. Prognosis, treatment, and disease outcomes in frontal fibrosing alopecia: a retrospective review of 92 cases. Journal of the American Academy of Dermatology. 2018;78(1):203-205.
Hamilton JB. Patterned loss of hair in man: types and incidence. Annals of the New York Academy of Sciences. 1951;53(3):708-728.
Norwood OT. Male pattern baldness: classification and incidence. Southern Medical Journal. 1975;68(11):1359-1365.